Rolf Stahel
Vermögen: 31 297 $ am 31.07.2026
Vermögen: 31 297 $ am 31.07.2026
Rolf Stahel is the founder and the Executive Chairman of Chesyl Pharma Ltd., which was founded in 1994.
He is also the Non-Executive Chairman of Ampha Ltd., starting in 2016.
Mr. Stahel's former positions include being the Chief Executive Officer of Shire Pharmaceuticals, Inc. from 1994 to 2003, the Non-Executive Chairman of EUSA Pharma, Inc., the Chairman of Cosmo Pharmaceuticals SA from 2006 to 2010, the Non-Executive Chairman of PowderMed Ltd. in 2006, the Non-Executive Chairman of Newron Pharmaceuticals SpA from 2012 to 2013, the Deputy Chairman of Cosmo Holding SpA in 2007, the Non-Executive Chairman of Connexios Life Sciences Pvt Ltd. from 2009 to 2016, the Non-Executive Chairman of Ergomed Plc from 2014 to 2017, the Non-Executive Chairman of Biodexa Pharmaceuticals Plc from 2014 to 2022, and the Director-Group Marketing of Wellcome Plc from 1967 to 1994.
Mr. Stahel's education includes an undergraduate degree from Kantons-schule.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
Hargreave Hale AIM VCT
Hargreave Hale AIM VCT Investment ManagersFinance Functions as a private equity fund 0.02% | 05.06.2026 | 76’000 ( 0.02% ) | 31 297 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Ampha Ltd.
Ampha Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorsitzender | 01.12.2016 |
| Unternehmen | Position | Ende |
|---|---|---|
Chesyl Pharma Ltd. | Gründer | 26.08.2024 |
| BIODEXA PHARMACEUTICALS PLC | Vorsitzender | 20.06.2022 |
| ERGOMED | Vorsitzender | 01.03.2017 |
Connexios Life Sciences Pvt Ltd.
Connexios Life Sciences Pvt Ltd. Pharmaceuticals: GenericHealth Technology Discovers and develops small molecule therapeutics | Vorsitzender | 01.01.2016 |
| NEWRON PHARMACEUTICALS S.P.A. | Vorsitzender | 18.04.2013 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 13 |
|---|---|
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and researches pharmaceutical products | Health Technology |
Cosmo Pharmaceuticals SA
Cosmo Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceutical company | Health Technology |
Wellcome Plc
Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Operates as a charitable foundation for healthcare | Commercial Services |
PowderMed Ltd.
PowderMed Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic products | Health Technology |
Newron Pharmaceuticals SpA
Newron Pharmaceuticals SpA Pharmaceuticals: MajorHealth Technology Develops and sells novel therapies central & peripheral nervous system | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Cosmo Holding SpA
Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Chesyl Pharma Ltd. | |
Connexios Life Sciences Pvt Ltd.
Connexios Life Sciences Pvt Ltd. Pharmaceuticals: GenericHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Kantons-schule
Kantons-schule Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ergomed Plc
Ergomed Plc BiotechnologyHealth Technology Engages in research and development of drugs for oncology & rare diseases | Health Technology |
Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Designs and manufactures nanomedicines | Health Technology |
Ampha Ltd.
Ampha Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen